Venture Capital Investors

Novo Ventures

Novo Ventures is a venture capital firm that assists tech entrepreneurs.

Venture Investor Overview

Venture Investor
Novo Ventures
Status
InActive
Investor Type
Venture Capital
Activity Level
165 transactions
Funds Raised
Unknown
Industry Focus
Advanced Materials
Biopharmaceutical
Clean Tech
Healthcare IT

Contact Information

Contact
Jack Nielson
Title
Partner
Mailing Address
Tuborg Havnevej 19
Hellerup, 2900
Denmark
Phone
+45 3527 6500
Website
www.novo.dk/composite-67.htm
Email Address
[email protected]

Background Information

Overview
Novo Ventures is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed and independently operating companies Novo Nordisk A/S and Novozymes A/S.
Profile
Novo Ventures LinkedIn Company Profile
Social Media
Novo Ventures Company Twitter Account
Company News
Novo Ventures News
Facebook
Novo Ventures on Facebook
YouTube
Novo Ventures on YouTube
Last Transaction
5/17/2022

Transaction History

Our records indicate that Novo Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Vestaron
5/17/2022
$82,000,000
Nuvig Therapeutics
5/12/2022
$47,000,000
Invetx
5/10/2022
$60,500,000
Engimmune Therapeutics
5/3/2022
$15,500,000
Precirix
3/24/2022
Unknown
Precirix
3/24/2022
$87,900,000
Biomason
3/16/2022
$65,000,000
Centauri Therapeutics
2/28/2022
$32,000,000
Metagenomi
2/2/2022
$175,000,000
Verana Health
1/25/2022
$150,000,000
MycoWorks
1/20/2022
$125,000,000
BIOMILQ
10/22/2021
$21,000,000
InBrace
9/9/2021
$102,000,000
Disc Medicine
9/2/2021
Unknown
Genomatica
7/28/2021
$118,000,000
Glycomine
6/24/2021
$68,000,000
Noom
5/26/2021
$540,000,000
Arcellx
4/14/2021
$115,000,000
StrideBio
3/17/2021
$81,500,000
Vestaron
2/18/2021
$18,000,000
Cyteir Therapeutics
2/12/2021
$80,000,000
Verve Therapeutics
1/20/2021
$94,000,000
MycoWorks
11/20/2020
$45,000,000
Stargazer Pharmaceuticals
11/10/2020
$57,000,000
Galecto
9/28/2020
$64,000,000
Lava Therapeutics
9/18/2020
$83,000,000
ReViral
8/26/2020
$44,000,000
Mission Bio
8/14/2020
$70,000,000
F2G
8/13/2020
$60,800,000
Praxis Precision Medicines
7/30/2020
$110,000,000
Bolt Biotherapeutics
7/2/2020
$93,500,000
Checkmate Pharmaceuticals
6/11/2020
$85,000,000
Avalyn Pharma
4/29/2020
$35,500,000
Kebotix
4/17/2020
$11,400,000
Tempus
3/17/2020
$100,000,000
MycoWorks
2/26/2020
$17,000,000
Spruce Biosciences
2/21/2020
$88,000,000
Disc Medicine
10/31/2019
$50,000,000
Allievex
10/24/2019
Unknown
Cyteir Therapeutics
10/16/2019
$40,200,000
Swift Health Systems
10/9/2019
$45,000,000
Arcellx
10/4/2019
$85,000,000
Edgewise Therapeutics
9/18/2019
$50,000,000
Nkarta
9/6/2019
$114,000,000
LanzaTech
8/8/2019
$72,000,000
Glycomine
8/8/2019
$33,000,000
Vestaron
6/11/2019
$40,000,000
Inozyme Pharma
4/11/2019
$67,000,000
Bolt Biotherapeutics
2/6/2019
$54,000,000
Aristea Therapeutics
12/19/2018
$15,000,000
Mirum Pharmaceuticals
11/8/2018
$120,000,000
Milestone Pharmaceuticals
10/26/2018
$80,000,000
Inspirna
10/10/2018
$40,000,000
Morphic Holding
9/26/2018
$80,000,000
Galera Therapeutics
9/21/2018
$150,000,000
MDLIVE
8/3/2018
$50,000,000
ViewPoint Therapeutics
3/12/2018
$35,000,000
Outpost Medicine
11/16/2017
$20,000,000
Inozyme Pharma
11/16/2017
$49,000,000
Spruce Biosciences
10/14/2017
$20,000,000
Harmony Biosciences
10/10/2017
$270,000,000
Entasis Therapeutics
9/6/2017
$31,900,000
Milestone Pharmaceuticals
7/26/2017
$55,000,000
Menlo Therapeutics
7/19/2017
$50,000,000
E-Scape Bio
7/13/2017
$63,000,000
Unchained Labs
7/1/2017
$13,000,000
Genoa Pharmaceuticals
5/16/2017
$62,000,000
Cirius Therapeutics
4/11/2017
$40,000,000
Tarveda Therapeutics
2/4/2017
$30,000,000
CorWave
11/8/2016
$17,100,000
Tioma Therapeutics
8/17/2016
$86,000,000
F2G
6/21/2016
$60,000,000
Inspirna
6/16/2016
$33,000,000
Entasis Therapeutics
4/5/2016
$50,000,000
Outpost Medicine
3/16/2016
$41,000,000
Unchained Labs
3/2/2016
$25,000,000
Tarveda Therapeutics
1/27/2016
$38,000,000
Corvus Pharmaceuticals
9/30/2015
$75,000,000
KalVista Pharmaceuticals
7/23/2015
$33,000,000
Ra Pharmaceuticals
7/23/2015
$58,500,000
Cianna Medical
7/17/2015
$8,000,000
AnaptysBio
7/16/2015
$40,000,000
Nuvelution Pharma
7/14/2015
Unknown
PROCEPT BioRobotics
7/8/2015
$42,000,000
Corvus Pharmaceuticals
7/1/2015
$33,500,000
Unum Therapeutics
6/11/2015
$65,000,000
iRhythm Technologies
3/31/2015
$10,000,200
Unchained Labs
2/16/2015
$25,000,000
CoLucid Pharmaceuticals
1/13/2015
$37,100,000
Allakos
9/30/2014
$10,000,000
iRhythm Technologies
5/22/2014
$17,000,000
Ceterix Orthopaedics
5/13/2014
$18,000,000
Otonomy
4/30/2014
$49,000,000
SI-BONE
4/28/2014
$33,000,000
Nora Therapeutics
4/17/2014
$18,000,000
PanOptica
4/15/2014
$45,000,000
Alios BioPharma
4/8/2014
$41,000,000
ZS Pharma
3/6/2014
$55,000,000
Thesan Pharmaceuticals
2/25/2014
$49,000,000
AlloCure
12/31/2013
$10,000,000
Otonomy
9/4/2013
Unknown
OphthoTech
5/29/2013
$175,000,000
Cardeas Pharma
5/23/2013
$34,000,000
PTC Therapeutics
3/8/2013
$60,000,000
Nevro
3/7/2013
$48,000,000
Ceterix Orthopaedics
1/22/2013
$19,500,000
Allakos
12/18/2012
$32,000,000
Flexion Therapeutics
12/4/2012
$20,000,000
Thesan Pharmaceuticals
11/1/2012
$16,000,000
PTC Therapeutics
7/24/2012
$30,000,000
Alder Biopharmaceuticals
4/19/2012
$38,000,000
Inogen
4/12/2012
$20,000,000
AlloCure
4/2/2012
$25,000,000
Tarsa Therapeutics
3/19/2012
$28,000,000
Altheos
2/9/2012
$12,500,000
Apollo Endosurgery
2/6/2012
$47,600,000
Elevation Pharmaceuticals
1/4/2012
$30,000,000
NeuroTherapeutics Pharma
12/31/2011
$12,000,200
Imagen Biotech
10/19/2011
$40,000,000
Otonomy
6/30/2011
$14,177,900
Cianna Medical
4/28/2011
$12,000,000
High Throughput Genomics
3/31/2011
$10,009,000
HTG Molecular Diagnostics
2/24/2011
$15,700,000
MediQuest Therapeutics
12/31/2010
$3,684,000
Tobira Therapeutics
9/30/2010
$31,000,000
Inogen
9/30/2010
$645,900
Otonomy
8/30/2010
$38,500,000
Reata Pharmaceuticals
7/12/2010
$78,000,000
FoldRx Pharmaceuticals
6/15/2010
$29,000,000
Logical Therapeutics
5/27/2010
$16,900,000
NeuroTherapeutics Pharma
5/20/2010
$43,000,000
Altheos
4/5/2010
$20,000,000
Inogen
3/31/2010
$9,000,000
NeoMend
1/27/2010
$30,000,000
PTC Therapeutics
12/23/2009
$50,000,000
Celion Networks
11/16/2009
$15,000,000
Metabolex
11/6/2009
$8,600,000
Tarsa Therapeutics
10/21/2009
$24,000,000
Lux Biosciences
10/19/2009
$50,000,000
Reata Pharmaceuticals
9/30/2009
$16,978,000
Celion Networks
4/10/2009
$10,000,000
Alios BioPharma
2/9/2009
$8,400,000
Logical Therapeutics
12/31/2008
$6,000,000
Reata Pharmaceuticals
12/31/2008
$30,705,400
AnaptysBio
9/30/2008
$504,900
Osprey Pharmaceuticals
9/3/2008
$11,000,000
AlloCure
7/2/2008
$14,500,000
OphthoTech
6/30/2008
$24,470,400
Inogen
12/31/2007
$12,648,000
AnaptysBio
11/8/2007
$33,900,000
Xencor
10/25/2007
$15,000,000
Reata Pharmaceuticals
7/6/2007
$25,000,000
Logical Therapeutics
6/13/2007
$30,000,000
Metabolex
4/19/2007
$32,000,000
Amira Pharmaceuticals
3/23/2007
$25,000,000
Inogen
2/16/2007
$22,000,000
Funxional Therapeutics
1/17/2007
$2,500,000
Synosia Therapeutics
1/5/2007
$32,500,000
Xencor
10/23/2006
$45,000,000
Kemia
8/23/2006
$31,000,000
Reata Pharmaceuticals
8/4/2006
$22,600,000
MediQuest Therapeutics
6/30/2006
$9,500,000
Synosia Therapeutics
6/30/2006
$30,000,100
CardioOptics
3/8/2006
$26,500,000
Kemia
3/29/2004
$33,500,000

 

Investor Contacts

Title
Name
Email & Social
Principal
Tiba Aynechi
  Tiba Aynechi LinkedIn Profile  Tiba Aynechi Twitter Account  Tiba Aynechi News  Tiba Aynechi on Facebook
Partner
Scott Beardsley
  Scott Beardsley LinkedIn Profile  Scott Beardsley Twitter Account  Scott Beardsley News  Scott Beardsley on Facebook
Senior Partner
Thomas Dyrberg
  Thomas Dyrberg LinkedIn Profile  Thomas Dyrberg Twitter Account  Thomas Dyrberg News  Thomas Dyrberg on Facebook
Senior Partner
Martin Edwards
  Martin Edwards LinkedIn Profile  Martin Edwards Twitter Account  Martin Edwards News  Martin Edwards on Facebook
Partner
Aleks Engel
  Aleks Engel LinkedIn Profile  Aleks Engel Twitter Account  Aleks Engel News  Aleks Engel on Facebook
Partner
Peter Moldt
  Peter Moldt LinkedIn Profile  Peter Moldt Twitter Account  Peter Moldt News  Peter Moldt on Facebook
Partner
Eric Shiozaki
  Eric Shiozaki LinkedIn Profile  Eric Shiozaki Twitter Account  Eric Shiozaki News  Eric Shiozaki on Facebook
Principal
Eric Snyder
  Eric Snyder LinkedIn Profile  Eric Snyder Twitter Account  Eric Snyder News  Eric Snyder on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Novo Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Alder Biopharmaceuticals
Alios BioPharma
Allakos
Allievex
AlloCure
Altheos
Amira Pharmaceuticals
AnaptysBio
Apollo Endosurgery
Arcellx
Aristea Therapeutics
Avalyn Pharma
Biomason
BIOMILQ
Bolt Biotherapeutics
Cardeas Pharma
CardioOptics
Celion Networks
Centauri Therapeutics
Ceterix Orthopaedics
Checkmate Pharmaceuticals
Cianna Medical
Cirius Therapeutics
CoLucid Pharmaceuticals
Corvus Pharmaceuticals
CorWave
Cyteir Therapeutics
Disc Medicine
E-Scape Bio
Edgewise Therapeutics
Elevation Pharmaceuticals
Engimmune Therapeutics
Entasis Therapeutics
F2G
Flexion Therapeutics
FoldRx Pharmaceuticals
Funxional Therapeutics
Galecto
Galera Therapeutics
Genoa Pharmaceuticals
Genomatica
Glycomine
Harmony Biosciences
High Throughput Genomics
HTG Molecular Diagnostics
Imagen Biotech
InBrace
Inogen
Inozyme Pharma
Inspirna
Invetx
iRhythm Technologies
KalVista Pharmaceuticals
Kebotix
Kemia
LanzaTech
Lava Therapeutics
Logical Therapeutics
Lux Biosciences
MDLIVE
MediQuest Therapeutics
Menlo Therapeutics
Metabolex
Metagenomi
Milestone Pharmaceuticals
Mirum Pharmaceuticals
Mission Bio
Morphic Holding
MycoWorks
NeoMend
NeuroTherapeutics Pharma
Nevro
Nkarta
Noom
Nora Therapeutics
Nuvelution Pharma
Nuvig Therapeutics
OphthoTech
Osprey Pharmaceuticals
Otonomy
Outpost Medicine
PanOptica
Praxis Precision Medicines
Precirix
PROCEPT BioRobotics
PTC Therapeutics
Ra Pharmaceuticals
Reata Pharmaceuticals
ReViral
SI-BONE
Spruce Biosciences
Stargazer Pharmaceuticals
StrideBio
Swift Health Systems
Synosia Therapeutics
Tarsa Therapeutics
Tarveda Therapeutics
Tempus
Thesan Pharmaceuticals
Tioma Therapeutics
Tobira Therapeutics
Unchained Labs
Unum Therapeutics
Verana Health
Verve Therapeutics
Vestaron
ViewPoint Therapeutics
Xencor
ZS Pharma

 

 

 

 

Browse more venture capital investors:

Novo Nordisk Biotech Fund | Novum Capital Partners

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.